Thalidomide in the treatment of graft-versus-host disease
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 44 (4), 199-204
- https://doi.org/10.1016/0753-3322(90)90024-4
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- THALIDOMIDE FOR CHRONIC GRAFT-VERSUS-HOST DISEASE IN CHILDRENThe Lancet, 1988
- THALIDOMIDE FOR SEVERE ACUTE GRAFT-VERSUS-HOST DISEASEThe Lancet, 1988
- THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASEThe Lancet, 1988
- SUCCESSFUL TREATMENT WITH THALIDOMIDE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATIONThe Lancet, 1988
- Quest to improve marrow transplant success yields new approaches to graft-vs-host diseasePublished by American Medical Association (AMA) ,1987
- TREATMENT AND PREVENTION OF ACUTE GRAFT-VERSUSHOST DISEASE WITH THALIDOMIDE IN A RAT MODELTransplantation, 1986
- Studies on the anti-inflammatory properties of thalidomide: Effects on polymorphonuclear leukocytes and monocytesJournal of the American Academy of Dermatology, 1984
- Thalidomide neurotoxicityArchives of Dermatology, 1984
- Prolongation of Skin Homograft Survival by ThalidomideBMJ, 1965
- Is Thalidomide to Blame?BMJ, 1960